Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease
NCT03806478
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Dementia
Alzheimer Disease 1
Alzheimer Disease 2
Alzheimer Disease 3
Interventions
DRUG:
APH-1105
OTHER:
Placebo
Sponsor
Aphios